Here are the S-3 shelf registrations from ClearPoint Neuro, Inc. (CLPT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow CLPT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLPT filings page.
ClearPoint Neuro, Inc. has filed a resale registration covering up to 1,312,570 shares of common stock that were issued or may be issued to former owners of IRRAS Holdings, Inc. in connection with a merger completed on November 20, 2025. These shares include 1,109,401 merger shares and up to 203,169 holdback shares that may be released if post-closing adjustment and indemnification conditions are met.
The company is not selling any shares under this prospectus and will not receive proceeds from sales by the selling stockholders. IRRAS adds a neurocritical care product focus to ClearPoint’s neurosurgical and biologics delivery platforms. As context, ClearPoint had 28,423,308 common shares outstanding as of October 27, 2025, and its stock last traded at $15.65 per share on January 12, 2026.